September 27, 2024, 10:26 AM - 5 min read
The arrival of GLP-1 analogue drugs (such as Wegovy) marked a huge shift in the weight loss drug market. These drugs have been shown to lead to significant weight loss in users – as much as 15% or more of their body weight in clinical trials.
Read more
August 7, 2024, 10:58 AM - 2 min read
Originally developed as a treatment for type 2 diabetes, so-called “skinny jabs” containing the appetite-suppressant semaglutide are a relatively recent innovation.
Read more
July 6, 2024, 12:08 PM - 2 min read
Patients using diabetes and weight-loss drugs Ozempic and Wegovy might face a higher risk of developing a serious eye condition. This condition, called a stroke of the optic nerve or NAION, can lead to blindness, as per new research findings.
Read more